 Home > Medical News > Latest Medical News > China Antibody Pharmaceutical's IND application for anti-IL-17RB antibody accepted by FDA

China Antibody Pharmaceutical's IND application for anti-IL-17RB antibody accepted by FDA

 Last Update: 2022-05-03
 Source: Internet
 Author: User

Tags

research development

new pharmaceutical companies

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On February 16, China Antibody Pharmaceutical Co.

Screenshot source: Reference [1]

According to the announcement, SM17 is a potential "first-in-class" humanized anti-IL-17RB monoclonal antibody for injection developed by China Antibody Pharmaceuticals

China Antibody Pharmaceuticals pointed out in the announcement that as a new approach for asthma treatment, therapies targeting upstream mediators of the Th2 inflammatory cytokine pathway (such as "vigilant") are expected to have a broader spectrum of pathological changes related to airway inflammation.

Public information shows that although approved severe asthma therapies (including biologics) can reduce the annual asthma exacerbation rate to a certain extent, there is still an unmet medical need for the effective treatment of severe asthma, especially those who do not respond to current therapies.

It is hoped that the follow-up studies of these new asthma therapies under development will proceed smoothly and bring new treatment options to patients as soon as possible

References:

[1] China Antibody Pharmaceutical Co.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.